NCT00174733View on ClinicalTrials.gov

Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid

PHASE3CompletedINTERVENTIONAL
Enrollment

456

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Asthma
Interventions
DRUG

Ciclesonide (XRP1526)

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY